Cita APA (7a ed.)
Yoshida, Y., Kiyono, Y., Tsujikawa, T., Kurokawa, T., Okazawa, H., & Kotsuji, F. (2011). Additional value of 16α-[F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [F]fluorodeoxyglucose PET. European Journal of Nuclear Medicine & Molecular Imaging, 38(10), 1824-1832.
Cita Chicago Style (17a ed.)
Yoshida, Yoshio, Yasushi Kiyono, Tetsuya Tsujikawa, Tetsuji Kurokawa, Hidehiko Okazawa, y Fumikazu Kotsuji. "Additional Value of 16α-[F]fluoro-17β-oestradiol PET for Differential Diagnosis Between Uterine Sarcoma and Leiomyoma in Patients with Positive or Equivocal Findings on [F]fluorodeoxyglucose PET." European Journal of Nuclear Medicine & Molecular Imaging 38, no. 10 (2011): 1824-1832.
Cita MLA (9a ed.)
Yoshida, Yoshio, et al. "Additional Value of 16α-[F]fluoro-17β-oestradiol PET for Differential Diagnosis Between Uterine Sarcoma and Leiomyoma in Patients with Positive or Equivocal Findings on [F]fluorodeoxyglucose PET." European Journal of Nuclear Medicine & Molecular Imaging, vol. 38, no. 10, 2011, pp. 1824-1832.
Precaución: Estas citas no son 100% exactas.